Loading...
Powered By
12 items
2025-06-21
HEROZ, Inc. provided consolidated earnings guidance for the year ending April 30, 2026. For the year, company expects net sales of JPY 6,700 million, operating profit of JPY 800 million, profit attributable to owners of parent of JPY 150 million and earnings per share of JPY 9.89.
2025-06-13
HEROZ, Inc., Annual General Meeting, Jul 25, 2025.
2025-06-04
HEROZ, Inc., 2025 Earnings Call, Jun 13, 2025
2025-05-30
HEROZ, Inc. revised consolidated earnings forecast for the fiscal year ending April 30, 2025. For the year, company revised net sales from JPY 6,000 million to JPY 5,929 million. The company expected operating profit of JPY 306 million from JPY 500 million earlier forecasted, loss attributable to owners of parent of JPY 177 million against net income of JPY 30 million earlier forecasted and loss per share of JPY 11.75 against net income per share of JPY 1.99 earlier forecasted.
2025-04-16
HEROZ, Inc. announced that they will report fiscal year 2025 results on Jun 13, 2025
2025-02-06
HEROZ, Inc., Q3 2025 Earnings Call, Mar 13, 2025
2025-02-04
HEROZ, Inc. expected to report Fiscal Year 2025 results on June 13, 2025. This event was calculated by S&P Global (Created on May 29, 2025).
2025-01-17
HEROZ, Inc. announced that they will report Q3, 2025 results on Mar 13, 2025
2024-12-13
HEROZ, Inc. expected to report Q3 2025 results on March 14, 2025. This event was calculated by S&P Global (Created on December 13, 2024).
2024-12-05
HEROZ, Inc., Q2 2025 Earnings Call, Dec 13, 2024
2024-10-09
HEROZ, Inc. announced that they will report Q2, 2025 results on Dec 13, 2024
2024-08-26
HEROZ, Inc., Board Meeting, Aug 23, 2024. Agenda: To Notice Concerning Issuance of New Shares as Remuneration for Restricted Stock.
2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | |
|---|---|---|---|---|---|---|---|---|
Total Revenues | 5,929 | 5,556 | 5,332 | 5,126 | 4,841 | 4,732 | 4,550 | 3,722 |
Pretax Income Excl.Unusual Items | 251 | 149 | 231 | 387 | 391 | 411 | 407 | 287 |
Total Assets | 8,147 | 7,947 | 8,108 | 8,006 | 7,691 | 7,634 | 8,517 | 8,479 |
Total Liabilities | 2,947 | 2,751 | 2,870 | 2,776 | 2,550 | 2,319 | 2,425 | 2,491 |
Cash & Cash Equivalents | 1,733 | 1,652 | 1,979 | 3,019 | 2,738 | 3,192 | 3,551 | 3,578 |
Total Common Equity | 4,637 | 4,698 | 4,780 | 4,813 | 4,787 | 4,996 | 5,875 | 5,835 |
Book Value Per Share (BVPS) | 305.58 | 311.69 | 317.12 | 319.91 | 318.18 | 332.06 | 390.61 | 388.3 |
Net Change in Cash | 404 | -549 | -1,056 | -145 | ||||
Capital Expenditure | -86 | -150 | -147 | -54 |
HEROZ revealed its financial results for the first quarter of 2025 on July 24, 2025, having revenues of 1.58B yen and net income of 3M yen, reflecting a significant 30.8% surge in revenue, with a transition from a loss per share in the same quarter last year to a profit per share in the current quarter. A positive note is that for the 9th consecutive quarter, the company's revenue line has increased compared to last year's corresponding quarter, which demonstrates the company's stability and its ability to grow in the future.
In addition, the EBITDA margin droped sharply from 29.8% in the corresponding quarter last year to 15.9%. A decrease in operating profitability may indicate a difficulty in sales or an increase in operating expenses, potentially harming the stock's future performance. and it trades at 3.77 times price to book ratio, which is higher than the industry average (P/B 1.74).